Clinical Overview

Ventricular flutter (VFL) is an extremely rapid ventricular tachyarrhythmia, generally driven by a single large reentrant circuit within the ventricular myocardium, that depolarizes the ventricles so fast the individual QRS complex, ST segment, and T wave can no longer be told apart on the surface ECG. Instead of the discrete, repeating complexes seen in ordinary ventricular tachycardia (VT), the trace merges into one continuous, regular, sine-wave-like oscillation.

VFL sits at the extreme end of the VT spectrum, bordering ventricular fibrillation (VF). Where monomorphic VT still shows individually identifiable, uniform QRS complexes and VF shows totally chaotic, disorganized deflections of varying amplitude, VFL is distinct from both: it is organized and monomorphic like VT, but so fast that its component waveforms are no longer separable, producing the smooth, regular sine-wave pattern. Current major arrhythmia guidelines classify ventricular arrhythmias primarily as monomorphic VT, polymorphic VT, or VF; “ventricular flutter” is a long-standing ECG-morphology descriptor for this fastest, sine-wave end of that spectrum rather than a separately risk-stratified guideline category. [CLINICAL REVIEW NEEDED: sources vary on whether VFL is best framed as an extreme form of VT or as a distinct sine-wave morphology that can arise from either fast monomorphic VT or organizing VF.]

Despite its organized appearance on the monitor, VFL produces the same catastrophic loss of coordinated ventricular contraction as VF: cardiac output falls precipitously and the rhythm is not compatible with a sustained pulse. VFL is characteristically short-lived and frequently degenerates into VF within moments, so in practice the two are treated as a continuum rather than as sharply separate clinical events.

Causes overlap heavily with VT and VF: ischemic heart disease and prior myocardial infarction, structural heart disease and cardiomyopathies, and inherited channelopathies (e.g., long QT syndrome, Brugada syndrome) all create substrate for this degree of ventricular instability. VFL can also be drug-induced — for example, administering an AV-nodal blocking agent such as intravenous verapamil to a patient with Wolff-Parkinson-White syndrome and a rapidly conducting accessory pathway has been documented to precipitate it. Severe electrolyte disturbance and other proarrhythmic triggers recognized for VT/VF apply here as well.

Because VFL causes immediate, severe hemodynamic compromise, there is no meaningful ongoing “symptom” period once it begins — patients lose effective cardiac output almost immediately. Some patients report preceding chest pain, palpitations, or lightheadedness before onset, and the rhythm typically culminates in sudden collapse, syncope, and unresponsiveness, the same presentation as VF and pulseless VT.

Interpretation Guide

Key Features:

• Rate: Extremely rapid; commonly described as roughly 200-300/min, with individual sources reporting ranges as wide as 200-350/min — no discrete beat-to-beat rate is countable once complexes merge
• Rhythm: Regular, monomorphic, continuous sine-wave oscillation — a single repeating waveform shape, unlike VF’s totally irregular chaos
• P waves: Absent; no atrial activity is discernible
• PR interval: Not measurable — no discrete P wave or QRS complex to measure between
• QRS complex: Not individually identifiable; merges into the continuous sine wave rather than appearing as discrete complexes
• ST segment: Not identifiable as a separate segment; folded into the sine-wave oscillation
• T waves: Not identifiable as a separate structure; folded into the sine-wave oscillation
• QT interval: Not measurable
• Other findings: The sine wave is a large-amplitude, uniform, regularly repeating oscillation, and — unusually among arrhythmias — looks essentially identical whether the strip is viewed right-side up or upside down. This uniform, repeating pattern is the key differentiator from VF, whose deflections vary irregularly in amplitude and shape from beat to beat with no repeating pattern.

The single most useful recognition step is comparing the waveform shape from cycle to cycle: a smooth, regular, repeating sine wave supports VFL, while irregular, constantly varying deflections support VF. Because VFL so often degenerates into VF within moments, this distinction matters less for immediate management (both are treated as cardiac arrest) than for correctly reading the strip.

Key Leads

VFL has no lead-preferred view. The large reentrant circuit driving it affects the ventricles as a whole rather than originating from one localized, lead-specific focus, so the sine-wave pattern appears throughout the tracing rather than being clearer in one lead than another.

Differential Diagnosis

• Ventricular Fibrillation (VF) — VF’s deflections are completely chaotic and irregular in amplitude and morphology from beat to beat, with no repeating pattern, versus VFL’s smooth, uniform, regularly repeating sine wave. VFL frequently degenerates into VF within moments, so overlap between the two on a real strip is expected, and both are managed identically as cardiac-arrest rhythms.
• Paroxysmal Ventricular Tachycardia (PVT / Ventricular Tachycardia) — VT, including monomorphic VT, still shows discrete, individually identifiable QRS complexes (uniform in shape in the monomorphic form), unlike VFL, whose rate is so extreme that individual QRS, ST, and T components can no longer be distinguished and instead merge into one continuous waveform.

Treatment Brief

VFL causes the same immediate, severe hemodynamic collapse as VF and pulseless VT, so it is managed as a cardiac arrest from the moment it is recognized: activate the emergency response system and begin high-quality chest compressions without delay.

VFL is a shockable rhythm on the ACLS pulseless-arrest algorithm — defibrillate as soon as a defibrillator is available (current guidance favors biphasic over monophasic waveforms), then resume CPR immediately rather than pausing to recheck rhythm or pulse right after the shock. If the rhythm persists despite defibrillation, epinephrine is given approximately every 3-5 minutes per ACLS protocol, and amiodarone may be considered for a refractory shockable rhythm. Minimizing interruptions to chest compressions — for rhythm checks, pulse checks, or shock delivery — is a priority throughout, since VFL is expected to be brief and frequently converts to VF if not immediately terminated.

After return of spontaneous circulation, longer-term management focuses on identifying and correcting reversible triggers (for example, avoiding AV-nodal blocking agents going forward in a patient with Wolff-Parkinson-White syndrome), evaluating underlying structural or ischemic heart disease, and considering an implantable cardioverter-defibrillator (ICD) to prevent recurrence.